SPAN developed a custom big data analysis platform enabling actionable insights on clinical trial execution performance and efficiency—all displayed on dynamic, web-based dashboards.
Working closely with Science 37 product and technical teams in a multi-phase project, we moved from ideation workshops through data modeling and system design, to implementation of a proprietary, configurable ingestion and data analysis tool that extends the value of their core platform.
The resulting system has empowered Science 37 to make better, data-driven decisions—informing strategic marketing efforts and driving operational excellence of ongoing trials. Since the project completed, Science 37 has gone public at a $1 billion valuation.
